# Axsome Therapeutics, Inc. (AXSM) stock price

URL: https://funkfolio.com/stock/AXSM

> Axsome Therapeutics, Inc. (AXSM) trades at $136.95, is worth $7.2B and scores 54/100. Valuation, financials and signals.

---

## Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM) is a healthcare company (biotechnology) based in the United States. The share price is $136.95, down 0.04% on the day, which values the company at $7.2B. Price as of 17 Nov 2026, 17:36 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $136.95 −0.04% today
- **Market value:** $7.2B
- **Forward P/E:** 37.6×
- **Funk Score:** 54/100
- **Against its own history:** About its usual price usual price $132.78
- **200-week average:** $115.17 19% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 17:36 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Axsome Therapeutics, Inc. in more detail

AXSM trades at 37.6× next year's expected earnings, 8.3× sales. Measured against its own history, the price is 3% above what its usual multiples would imply ($132.78) — about its usual price. It sits 19% above its 200-week average of $115.17.

Its Funk Score is 54 out of 100 (financial strength 6.4, profitability 2.5, growth 10.0, value 2.6, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Share count keeps rising; Thin interest cover.

### Health Care companies of similar size

- [ABIVAX ABVX](https://funkfolio.com/stock/ABVX)
- [Bausch + Lomb BLCO](https://funkfolio.com/stock/BLCO)
- [Amneal Pharmaceuticals AMRX](https://funkfolio.com/stock/AMRX)
- [Caris Life Sciences CAI](https://funkfolio.com/stock/CAI)
- [Immunovant IMVT](https://funkfolio.com/stock/IMVT)
- [Chemed CHE](https://funkfolio.com/stock/CHE)
- [Oruka Therapeutics ORKA](https://funkfolio.com/stock/ORKA)
- [Arrowhead Pharmaceuticals ARWR](https://funkfolio.com/stock/ARWR)
- [MSA Safety MSA](https://funkfolio.com/stock/MSA)
- [CG Oncology CGON](https://funkfolio.com/stock/CGON)
- [Kodiak Sciences KOD](https://funkfolio.com/stock/KOD)
- [Lantheus Holdings LNTH](https://funkfolio.com/stock/LNTH)

Side by side: [AXSM vs CHE (Axsome Therapeutics, Inc. vs Chemed)](https://funkfolio.com/compare/axsm-vs-che) [AXSM vs ORKA (Axsome Therapeutics, Inc. vs Oruka Therapeutics)](https://funkfolio.com/compare/axsm-vs-orka) [AXSM vs ARWR (Axsome Therapeutics, Inc. vs Arrowhead Pharmaceuticals)](https://funkfolio.com/compare/arwr-vs-axsm) [AXSM vs IMVT (Axsome Therapeutics, Inc. vs Immunovant)](https://funkfolio.com/compare/axsm-vs-imvt) [AXSM vs MSA (Axsome Therapeutics, Inc. vs MSA Safety)](https://funkfolio.com/compare/axsm-vs-msa)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Axsome Therapeutics, Inc. (AXSM): questions and answers

**What is Axsome Therapeutics, Inc.'s market cap?**

Axsome Therapeutics, Inc. is valued at $7.2B at a share price of $136.95.

**Is AXSM overvalued or undervalued?**

Against its own history, AXSM is about its usual price: the price is 3% above the $132.78 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is AXSM above its 200-week moving average?**

Yes. AXSM is 18.9% above its 200-week average of $115.17. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Axsome Therapeutics, Inc. growing?**

Over the last three fiscal years Axsome Therapeutics, Inc.'s revenue grew 133.7% a year.

**Does AXSM pay a dividend?**

Axsome Therapeutics, Inc. does not currently pay a regular dividend.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Axsome Therapeutics, Inc. (AXSM) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AXSM

Underlying data: Yahoo Finance; company filings with the SEC.
